Company Profile
Updated: 27-OCT-09Docpharma S.A./NV
Non-Quoted Public Company
Ambachtenlaan 13H, Heverlee, B-3001, Belgium
()32 016 38 92 77, 32 016 38 92 78 fax, http://www.docpharma.com
Primary SIC: Stationery Supplies, Primary NAICS: Stationery and Office Supplies Merchant Wholesalers
Description: Wholesale: Wholesale trade in and distribution of pharmaceuticals and medical equipment
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
CRISIL confirms at A-/P1 ratings of Matrix.
ADP Debt News; 8/25/2009; 1089 words; ...are partially offset by Matrix's highly leveraged capital structure...profitability of its European subsidiary, Docpharma NV, coupled with large write-offs...diminution in the value of Matrix's investment in Docpharma, and the increasing competition...
Rising Players in Global Fine Chemicals
Pharmaceutical Technology; 7/1/2006; 2861 words; ...December 2004 and Avecia's custom manufacturing business...ventures with South Africa's Aspen Pharmacare, and bought...Belgium generics company Docpharma NV. Other recent moves includes...acquisition of Rhodia's pharmaceutical custom synthesis...
Popping Growth Pills Overseas acquisitions have become generic to Indian pharmaceuticals. Apart from boosting market share, the buyouts promise to expand product lines and size, and catapult them into the big league.
India Today; 4/17/2006; 1772 words; ...overseas acquisition was UK's BMS Laboratories Limited...2002. Since then, DRL's generic sales in the UK...round two acquisition of Docpharma in May-June last year...cent in 2007-08. It's also hoping its revenues...in addition to Ethimed NV's share of the $7...
Mumbai, Oct 5 (PTI) Matrix Laboratories Ltd today its Belgian subsidiary, Matrix Laboratories NV has acquired 46.44 lakh equity shares of Belgium-based Docpharma.
PTI - The Press Trust of India Ltd.; 10/5/2005; 413 words; ...raising Matrix's shareholding up to 95.51 per cent in Docpharma, it informed the...Matrix Laboratories NV will bring a public...for all remaining Docpharma shares which were...Matrix Laboratories NV, with consignation...squeeze-out bid, Docpharma shares will be delisted...
Alpharma Puts Itself In Play.
Mergers & Acquisitions Report; 9/12/2005; 1008 words; ...deals include Novartis AG's June purchase of Hexal AG...about 60% of Alpharma's revenue. The rest of the...buyout of Belgian drug maker Docpharma NV for $238 million, adjusted...about 1.4 times RPG's 52 million euros in 2003...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning